Immunomodulation by vitamin D: Implications for TB

Expert Review of Clinical Pharmacology

Volumn 4, Issue 5, 2011, Pages 583-591

  Chun, Rene F ^a   Adams, John S ^a   Hewison, Martin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cathelicidin; CYP24A1; CYP27B1; defensins; monocyte; neutrophil; TB; Toll like receptor; vitamin D; vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; 7 DEHYDROCHOLESTEROL; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLECALCIFEROL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 1BETA; MACROPHAGE ACTIVATING FACTOR; PHTHALIC ACID DIBUTYL ESTER; VITAMIN D; VITAMIN D BINDING PROTEIN;

ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOAVAILABILITY; CYTOKINE PRODUCTION; DRUG MEGADOSE; GENOTYPE; HUMAN; IMMUNE DYSREGULATION; IMMUNOMODULATION; INNATE IMMUNITY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); TH1 CELL; TH17 CELL; TRANSCRIPTION REGULATION; TUBERCULIN TEST; TUBERCULOSIS; URINARY EXCRETION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN D RESPONSIVE ELEMENT; VITAMIN SUPPLEMENTATION;

ADAPTIVE IMMUNITY; ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; TUBERCULOSIS, PULMONARY; VITAMIN D;

EID: 80052694125     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/ecp.11.41     Document Type: Article

References (117)

1. Holick MF. Vitamin D deficiency. N. Engl. J. Med. 357(3), 266-281 (2007).
2. Adams JS, Hewison M. Update in vitamin D. J. Clin. Endocrinol. Metab. 95(2), 471-478 (2010).
3. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80(Suppl. 6), 1689S-1696S (2004).
4. Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives from mice and man. J. Bone Miner. Res. 23(7), 974-979 (2008). (Pubitemid 351915717)
5. Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J. Clin. Endocrinol. Metab. 61(5), 969-975 (1985). (Pubitemid 16218499)
6. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab. 63(4), 954-959 (1986). (Pubitemid 16004301)
7. Nykjaer A, Dragun D, Walther D et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96(4), 507-515 (1999). (Pubitemid 29106838)
8. Bikle DD, Gee E. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124(2), 649-654 (1989). (Pubitemid 19057050)
9. Chun RF, Lauridsen AL, Suon L et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 95(7), 3368-3376 (2010).
10. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149(7), 3656-3667 (2008). (Pubitemid 351919607)
11. MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C. Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids 66(3-5), 171-176 (2001). (Pubitemid 32143674)
12. Pike JW, Meyer MB, Watanuki M et al. Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J. Steroid Biochem. Mol. Biol. 103(3-5), 389-395 (2007).
13. Adams JS, Gacad MA. Characterization of 1 α-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J. Exp. Med. 161(4), 755-765 (1985). (Pubitemid 15083775)
14. Dusso A, Brown A, Slatopolsky E. Extrarenal production of calcitriol. Semin. Nephrol. 14(2), 144-155 (1994). (Pubitemid 24083805)
15. Farooque A, Moss C, Zehnder D, Hewison M, Shaw NJ. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in subcutaneous fat necrosis. Br. J. Dermatol. 160(2), 423-425 (2009).
16. Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1 α-hydroxylase. J. Clin. Endocrinol. Metab. 86(2), 888-894 (2001). (Pubitemid 32207511)
17. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10(4), 482-496 (2010).
18. Maruotti N, Cantatore FP. Vitamin D and the immune system. J. Rheumatol. 37(3), 491-495 (2010).
19. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am. 39(2), 365-379 (2010).
20. Grad R. Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm. Hist. 46(3), 106-120 (2004).
21. Rook GA, Steele J, Fraher L et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57(1), 159-163 (1986). (Pubitemid 16232232)
22. Koeffler HP, Reichel H, Bishop JE, Norman AW. γ-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem. Biophys. Res. Commun. 127(2), 596-603 (1985). (Pubitemid 16217468)
23. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768), 1770-1773 (2006).
24. Nelson CD, Reinhardt TA, Beitz DC, Lippolis JD. In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PloS one 5(11), e15469 (2010).
25. Wang TT, Nestel FP, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173(5), 2909-2912 (2004). (Pubitemid 39141992)
26. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19(9), 1067-1077 (2005). (Pubitemid 40946432)
27. Adams JS, Ren S, Liu PT et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol. 182(7), 4289-4295 (2009).
28. Gombart AF, Saito T, Koeffler HP. Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 10, 321 (2009).
29. Liu PT, Schenk M, Walker VP et al. Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PloS one 4(6), e5810 (2009).
30. Wang TT, Dabbas B, Laperriere D et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/ CARD15-b defensin 2 innate immune pathway defective in Crohn's disease. J. Biol. Chem. 285(4), 2227-2231 (2010).
31. Crotzer VL, Blum JS. Autophagy and adaptive immunity. Immunology 131(1), 9-17 (2010).
32. Jo EK. Innate immunity to mycobacteria: vitamin D and autophagy. Cell. Microbiol. 12(8), 1026-1035 (2010).
33. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 469(7330), 323-335 (2011).
34. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119(6), 753-766 (2004). (Pubitemid 40017683)
35. Deretic V, Delgado M, Vergne I et al. Autophagy in immunity against Mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Curr. Top. Microbiol. Immunol. 335, 169-188 (2009).
36. Yuk JM, Shin DM, Lee HM et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6(3), 231-243 (2009).
37. Shin DM, Yuk JM, Lee HM et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signaling. Cell. Microbiol. 12(11), 1648-1665 (2010).
38. Sly LM, Lopez M, Nauseef WM, Reiner NE. 1α,25-Dihydroxyvitamin D3- induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 276(38), 35482-35493 (2001).
39. Yang CS, Shin DM, Kim KH et al. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J. Immunol. 182(6), 3696-3705 (2009).
40. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175(4), 1111-1122 (1992).
41. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94(10), 5243-5248 (1997). (Pubitemid 27214768)
42. Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR, Lapae Silva JR et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183(5), 2293-2302 (1996). (Pubitemid 26158920)
43. Waters WR, Palmer MV, Nonnecke BJ, Whipple DL, Horst RL. Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb. Pathog. 36(1), 11-17 (2004). (Pubitemid 37476185)
44. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun. 66(11), 5314-5321 (1998). (Pubitemid 29044625)
45. Rivas-Santiago B, Hernandez-Pando R, Carranza C et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect. Immun. 76(3), 935-941 (2008). (Pubitemid 351428052)
46. Martineau AR, Wilkinson KA, Newton SM et al. IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol. 178(11), 7190-7198 (2007). (Pubitemid 46847445)
47. Edfeldt K, Liu PT, Chun R et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. USA 107(52), 22593-22598 (2010).
48. Krutzik SR, Hewison M, Liu PT et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181(10), 7115-7120 (2008).
49. Harris J, Hope JC, Keane J. Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis. J. Infect. Dis. 198(12), 1842-1850 (2008).
50. Master SS, Rampini SK, Davis AS et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 3(4), 224-232 (2008). (Pubitemid 351494718)
51. Schaible UE, Sturgill-Koszycki S, Schlesinger PH, Russell DG. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160(3), 1290-1296 (1998). (Pubitemid 28093427)
52. Via LE, Fratti RA, McFalone M, Pagan- Ramos E, Deretic D, Deretic V. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111(Pt 7), 897-905 (1998). (Pubitemid 28196073)
53. Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin. Exp. Immunol. 161(1), 1-9 (2010).
54. Shi CS, Kehrl JH. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci. Signal. 3(123), ra42 (2010).
55. Harris J, De Haro SA, Master SS et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis Immunity 27(3), 505-517 (2007). (Pubitemid 47418681)
56. Karmali R, Hewison M, Rayment N et al. 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 74(4), 589-593 (1991).
57. Nunn JD, Katz DR, Barker S et al. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology 59(4), 479-484 (1986). (Pubitemid 17178266)
58. Provvedini DM, Manolagas SC. 1 A,25- dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J. Clin. Endocrinol. Metab. 68(4), 774-779 (1989). (Pubitemid 19089008)
59. Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol. 53(1-6), 599-602 (1995).
60. Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol. Aspects Med. 29(6), 369-375 (2008).
61. Overbergh L, Decallonne B, Waer M et al. 1a,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).Diabetes 49(8), 1301-1307 (2000). (Pubitemid 30624229)
62. + T cells to enhance the development of Th2 cells. J. Immunol. 167(9), 4974-4980 (2001). (Pubitemid 33009728)
63. Harris J, Master SS, De Haro SA et al. Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages. Vet. Immunol. Immunopathol. 128(1-3), 37-43 (2009).
64. Salgame P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol. 17(4), 374-380 (2005). (Pubitemid 40848539)
65. Abebe F, Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 157(2), 235-243 (2009).
66. Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. J. Immunol. 185(1), 15-22 (2010).
67. Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr. Allergy Asthma Rep. 11(1), 29-36 (2011).
68. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 α,25- dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167(4), 1945-1953 (2001). (Pubitemid 32747499)
69. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195(5), 603-616 (2002).
70. + cells in the draining lymph nodes. J. Immunol. 179(9), 6273-6283 (2007).
71. Dong X, Bachman LA, Kumar R, Griffin MD. Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl. Immunol. 11(3-4), 323-333 (2003). (Pubitemid 37120551)
72. Adorini L, Penna G, Giarratana N et al. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J. Steroid Biochem. Mol. Biol. 89-90(1-5), 437-441 (2004). (Pubitemid 38844326)
73. Urry Z, Xystrakis E, Richards DF et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest. 119(2), 387-398 (2009).
74. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1α,25- dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51(5), 1367-1374 (2002). (Pubitemid 34826601)
75. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol. Metab. 16(6), 261-266 (2005). (Pubitemid 41058757)
76. Spach KM, Nashold FE, Dittel BN, Hayes CE. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 177(9), 6030-6037 (2006). (Pubitemid 44628817)
77. + regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol. 123(1), 50-59 (2007). (Pubitemid 46420558)
78. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6(11), 1123-1132 (2005). (Pubitemid 41541790)
79. Liu N, Nguyen L, Chun RF et al. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 149(10), 4799-4808 (2008).
80. Chang SH, Chung Y, Dong C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J. Biol. Chem. 285(50), 38751-38755 (2010).
81. Colin EM, Asmawidjaja PS, van Hamburg JP et al. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 62(1), 132-142 (2010).
82. Wozniak TM, Saunders BM, Ryan AA, Britton WJ. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect. Immun. 78(10), 4187-4194 (2010).
83. Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J. Infect. Dis. 201(1), 20-31 (2010).
84. Wejse C, Olesen R, Rabna P et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am. J. Clin. Nutr. 86(5), 1376-1383 (2007). (Pubitemid 350126241)
85. Williams B, Williams AJ, Anderson ST. Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr. Infect. Dis. J. 27(10), 941-942 (2008).
86. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J. Infect. 50(5), 432-437 (2005). (Pubitemid 40692029)
87. Wilkinson RJ, Llewelyn M, Toossi Z et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case-control study. Lancet 355(9204), 618-621 (2000). (Pubitemid 30099469)
88. Talat N, Perry S, Parsonnet J, Dawood G, Hussain R. Vitamin D deficiency and tuberculosis progression. Emerg. Infect. Dis. 16(5), 853-855 (2010).
89. Bischoff-Ferrari HA, Kiel DP, Dawson- Hughes B et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J. Bone Miner. Res. 24(5), 935-942 (2009).
90. Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96(1), 53-58 (2011).
91. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid Biochem. Mol. Biol. 103(3-5), 793-798 (2007). (Pubitemid 46401341)
92. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 37(1), 113-119 (2008). (Pubitemid 351228619)
93. Martineau AR, Wilkinson RJ, Wilkinson KA et al. A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 176(2), 208-213 (2007). (Pubitemid 47057859)
94. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones. 38(1), 3-5 (2006).
95. Martineau AR, Timms PM, Bothamley GH et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377(9761), 242-250 (2011).
96. Wejse C, Gomes VF, Rabna P et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 179(9), 843-850 (2009).
97. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 338(2), 143-156 (2004). (Pubitemid 39094759)
98. Arai H, Miyamoto K, Taketani Y et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner. Res. 12(6), 915-921 (1997). (Pubitemid 27225001)
99. Zhang HQ, Deng A, Guo CF et al. Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. Arch. Med. Res. 41(1), 46-49 (2010).
100. Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 14(1), 15-23 (2010).
101. Lewis SJ, Baker I, Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int. J. Tuberc. Lung Dis. 9(10), 1174-1177 (2005). (Pubitemid 41433810)
102. Soborg C, Andersen AB, Range N et al. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol. Immunol. 44(9), 2213-2220 (2007). (Pubitemid 46110907)
103. Schaaf MJ, Cidlowski JA. AUUUA motifs in the 3'UTR of human glucocorticoid receptor α and β mRNA destabilize mRNA and decrease receptor protein expression. Steroids 67(7), 627-636 (2002). (Pubitemid 34462990)
104. Ates O, Dolek B, Dalyan L, Musellim B, Ongen G, Topal-Sarikaya A. The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis. Mol. Biol. Rep. 38(4), 2633-2636 (2011).
105. Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP).Hum. Genet. 92(2), 183-188 (1993). (Pubitemid 23272286)
106. Kamboh MI, Ferrell RE. Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum. Genet. 72(4), 281-293 (1986). (Pubitemid 16087987)
107. Wang TJ, Zhang F, Richards JB et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376(9736), 180-188 (2010).
108. Ahn J, Yu K, Stolzenberg-Solomon R et al. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 19(13), 2739-2745 (2010).
109. Yamamoto N, Kumashiro R. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells. J. Immunol. 151(5), 2794-2802 (1993). (Pubitemid 23264531)
110. Mohamad SB, Nagasawa H, Uto Y, Hori H. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities. Anticancer Res. 22(6C), 4297-4300 (2002). (Pubitemid 36134476)
111. Wood AM, Bassford C, Webster D et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax 66(3), 205-210 (2011).
112. Martineau AR, Leandro AC, Anderson ST et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur. Respir. J. (2009).
113. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann. Epidemiol. (2008).
114. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos. Int. 16(7), 713-716 (2005). (Pubitemid 40933586)
115. Dunn JF. Computer simulation of vitamin D transport. Ann. NY Acad. Sci. 538, 69-76 (1988). (Pubitemid 19021455)
116. Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin. Chem. 47(4), 753-756 (2001). (Pubitemid 32275824)
117. Gibney KB, MacGregor L, Leder K et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin. Infect. Dis. 46(3), 443-446 (2008) (Pubitemid 351263529)